chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Rash macular, Vaccination site mass, Vaccination site pruritus
Clinical narrative: spot at injection site; large lump at injection site; itchy at injection site; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 10-Feb-2021 and was forwarded to Moderna on 10-Feb-2021.    This spontaneous case was reported by a consumer and describes the occurrence of RASH MACULAR (spot at injection site), VACCINATION SITE MASS (large lump at injection site) and VACCINATION SITE PRURITUS (itchy at injection site) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021, the patient experienced RASH MACULAR (spot at injection site), VACCINATION SITE MASS (large lump at injection site) and VACCINATION SITE PRURITUS (itchy at injection site). At the time of the report, RASH MACULAR (spot at injection site), VACCINATION SITE MASS (large lump at injection site) and VACCINATION SITE PRURITUS (itchy at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.      Details regarding concomitant medication and treatment medications were not provided.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Exposure to SARS-CoV-2
Clinical narrative: is expose to covid-19 positive student; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 11-Feb-2021 and was forwarded to Moderna on 11-Feb-2021.    This spontaneous case was reported by a consumer and describes the occurrence of EXPOSURE TO SARS-COV-2 (is expose to covid-19 positive student) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPOSURE TO SARS-COV-2 (is expose to covid-19 positive student). At the time of the report, EXPOSURE TO SARS-COV-2 (is expose to covid-19 positive student) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       The patient wanted to confirm if her exposure to covid-19 student would affect her getting her second dose or not that was scheduled on 14-Feb-2021 or not.   Reporter did not allow further contact
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Myalgia, Pyrexia, Vaccination site pain
Clinical narrative: fever; chills; bodyache; soreness on site of injection; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever), CHILLS (chills), MYALGIA (bodyache) and VACCINATION SITE PAIN (soreness on site of injection) in a 30-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028C20A) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Feb-2021, the patient experienced PYREXIA (fever), CHILLS (chills), MYALGIA (bodyache) and VACCINATION SITE PAIN (soreness on site of injection). At the time of the report, PYREXIA (fever), CHILLS (chills), MYALGIA (bodyache) and VACCINATION SITE PAIN (soreness on site of injection) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant and treatment medication reported.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Body temperature, Chills, Headache, Neck pain
Clinical narrative: Severe chills; Joint pain; Fever; headache; neck pain; This spontaneous case was reported by a health care professional and describes the occurrence of NECK PAIN (neck pain), CHILLS (Severe chills), ARTHRALGIA (Joint pain), PYREXIA (Fever) and HEADACHE (headache) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination.     Concurrent medical conditions included Rheumatoid arthritis and Migraine. Concomitant products included ZOLMITRIPTAN (ZOMIG) for Migraine, HYDROXYCHLOROQUINE for Rheumatoid arthritis, OMEPRAZOLE for an unknown indication.   On 10-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, the patient experienced NECK PAIN (neck pain) and HEADACHE (headache). On 11-Feb-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced CHILLS (Severe chills), ARTHRALGIA (Joint pain) and PYREXIA (Fever). On 11-Feb-2021, CHILLS (Severe chills) had resolved. On 13-Feb-2021, NECK PAIN (neck pain) and HEADACHE (headache) had resolved. At the time of the report, ARTHRALGIA (Joint pain) and PYREXIA (Fever) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 11-Feb-2021, Body temperature: 101.4f (High) Fever got to 101.4F.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The patient was on hormone replacement therapy. Treatment information for the event  was not reported action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), was unknown   Most recent FOLLOW-UP information incorporated above includes: On 28-Apr-2021: Additional information received included reporter details. On 18-May-2021: New AE Added
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Severe chills; Joint pain; Fever; headache; neck pain; This spontaneous case was reported by a health care professional and describes the occurrence of NECK PAIN (neck pain), CHILLS (Severe chills), ARTHRALGIA (Joint pain), PYREXIA (Fever) and HEADACHE (headache) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination.     Concurrent medical conditions included Rheumatoid arthritis and Migraine. Concomitant products included ZOLMITRIPTAN (ZOMIG) for Migraine, HYDROXYCHLOROQUINE for Rheumatoid arthritis, OMEPRAZOLE for an unknown indication.   On 10-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, the patient experienced NECK PAIN (neck pain) and HEADACHE (headache). On 11-Feb-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced CHILLS (Severe chills), ARTHRALGIA (Joint pain) and PYREXIA (Fever). On 11-Feb-2021, CHILLS (Severe chills) had resolved. On 13-Feb-2021, NECK PAIN (neck pain) and HEADACHE (headache) had resolved. At the time of the report, ARTHRALGIA (Joint pain) and PYREXIA (Fever) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 11-Feb-2021, Body temperature: 101.4f (High) Fever got to 101.4F.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The patient was on hormone replacement therapy. Treatment information for the event  was not reported action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), was unknown   Most recent FOLLOW-UP information incorporated above includes: On 28-Apr-2021: Additional information received included reporter details. On 18-May-2021: New AE Added
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Influenza like illness, Myalgia, Nasopharyngitis
Clinical narrative: cold; weak; flu-like symptoms; body aches; This spontaneous case was reported by a consumer and describes the occurrence of NASOPHARYNGITIS (cold), ASTHENIA (weak), INFLUENZA LIKE ILLNESS (flu-like symptoms) and MYALGIA (body aches) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History Information was reported.     On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced NASOPHARYNGITIS (cold), ASTHENIA (weak), INFLUENZA LIKE ILLNESS (flu-like symptoms) and MYALGIA (body aches). At the time of the report, NASOPHARYNGITIS (cold), ASTHENIA (weak), INFLUENZA LIKE ILLNESS (flu-like symptoms) and MYALGIA (body aches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported.  No treatment information was provided. This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 09-Feb-2021 and was forwarded to Moderna on 10-Feb-2021.    This spontaneous case was reported by a consumer and describes the occurrence of NASOPHARYNGITIS (cold), ASTHENIA (weak), INFLUENZA LIKE ILLNESS (flu-like symptoms) and MYALGIA (body aches) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History Information was reported.     On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced NASOPHARYNGITIS (cold), ASTHENIA (weak), INFLUENZA LIKE ILLNESS (flu-like symptoms) and MYALGIA (body aches). At the time of the report, NASOPHARYNGITIS (cold), ASTHENIA (weak), INFLUENZA LIKE ILLNESS (flu-like symptoms) and MYALGIA (body aches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported.  No treatment information was provided.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Myalgia, Pyrexia
Clinical narrative: chilled; sore arm; fever; fatigued; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 10-Feb-2021 and was forwarded to the company on 11-Feb-2021.    This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (sore arm), PYREXIA (fever), FATIGUE (fatigued) and CHILLS (chilled) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M2A) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Feb-2021, the patient experienced MYALGIA (sore arm), PYREXIA (fever) and FATIGUE (fatigued). On 11-Feb-2021, the patient experienced CHILLS (chilled). The patient was treated with IBUPROFEN ongoing since an unknown date for Myalgia and Fever, at an unspecified dose and frequency and NAPROXEN SODIUM (ALEVE) ongoing since an unknown date for Myalgia and Fever, at an unspecified dose and frequency. On 10-Feb-2021, PYREXIA (fever) and FATIGUE (fatigued) had resolved. At the time of the report, MYALGIA (sore arm) and CHILLS (chilled) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       The patent reported that following treatment with Ibuprofen and Aleve, there was improvement in fever and sore arm, however she still had a slightly sore arm. She also reported that her chills improved after she ate something.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Erythema, Injection site erythema, Injection site swelling, Injection site warmth
Clinical narrative: Nausea; beat red; hot; Rash looked like a bullseye about 3inches in diameter going down her arm; pain in shoulder; swelling at the injection site; redness at the injection site; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 10-Feb-2021 and was forwarded to Moderna on 10-Feb-2021.    This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (beat red), INJECTION SITE WARMTH (hot), INJECTION SITE ERYTHEMA (redness at the injection site), RASH PAPULAR (Rash looked like a bullseye about 3inches in diameter going down her arm) and ARTHRALGIA (pain in shoulder) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 0266204) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Hypothyroidism, Pancreatitis and Gastritis. Concurrent medical conditions included Drug allergy (Opiate drugs), Drug allergy (Demerol), Drug allergy (Diloxin), Drug allergy (Neurontin) and Allergy to chemicals (CT-scan dye). Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID) and OMEPRAZOLE (PROTONIX [OMEPRAZOLE]) for an unknown indication.    On 01-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Feb-2021, the patient experienced INJECTION SITE ERYTHEMA (redness at the injection site), ARTHRALGIA (pain in shoulder) and INJECTION SITE SWELLING (swelling at the injection site). On 09-Feb-2021, the patient experienced ERYTHEMA (beat red), INJECTION SITE WARMTH (hot) and RASH PAPULAR (Rash looked like a bullseye about 3inches in diameter going down her arm). On an unknown date, the patient experienced NAUSEA (Nausea). At the time of the report, ERYTHEMA (beat red), INJECTION SITE WARMTH (hot), INJECTION SITE ERYTHEMA (redness at the injection site), RASH PAPULAR (Rash looked like a bullseye about 3inches in diameter going down her arm), ARTHRALGIA (pain in shoulder), INJECTION SITE SWELLING (swelling at the injection site) and NAUSEA (Nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       The patient reported that she had swelling and redness at the injection site. She also was nauseas. 8 days later, she had pain in shoulder. She looked and noticed rash. It looked like a bullseye about 3 inches in diameter. It was hot and beat red and was going down her arm. She wanted to know if this was normal or not. Treatment details were not reported.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Rash papular
Clinical narrative: Nausea; beat red; hot; Rash looked like a bullseye about 3inches in diameter going down her arm; pain in shoulder; swelling at the injection site; redness at the injection site; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 10-Feb-2021 and was forwarded to Moderna on 10-Feb-2021.    This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (beat red), INJECTION SITE WARMTH (hot), INJECTION SITE ERYTHEMA (redness at the injection site), RASH PAPULAR (Rash looked like a bullseye about 3inches in diameter going down her arm) and ARTHRALGIA (pain in shoulder) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 0266204) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Hypothyroidism, Pancreatitis and Gastritis. Concurrent medical conditions included Drug allergy (Opiate drugs), Drug allergy (Demerol), Drug allergy (Diloxin), Drug allergy (Neurontin) and Allergy to chemicals (CT-scan dye). Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID) and OMEPRAZOLE (PROTONIX [OMEPRAZOLE]) for an unknown indication.    On 01-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Feb-2021, the patient experienced INJECTION SITE ERYTHEMA (redness at the injection site), ARTHRALGIA (pain in shoulder) and INJECTION SITE SWELLING (swelling at the injection site). On 09-Feb-2021, the patient experienced ERYTHEMA (beat red), INJECTION SITE WARMTH (hot) and RASH PAPULAR (Rash looked like a bullseye about 3inches in diameter going down her arm). On an unknown date, the patient experienced NAUSEA (Nausea). At the time of the report, ERYTHEMA (beat red), INJECTION SITE WARMTH (hot), INJECTION SITE ERYTHEMA (redness at the injection site), RASH PAPULAR (Rash looked like a bullseye about 3inches in diameter going down her arm), ARTHRALGIA (pain in shoulder), INJECTION SITE SWELLING (swelling at the injection site) and NAUSEA (Nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       The patient reported that she had swelling and redness at the injection site. She also was nauseas. 8 days later, she had pain in shoulder. She looked and noticed rash. It looked like a bullseye about 3 inches in diameter. It was hot and beat red and was going down her arm. She wanted to know if this was normal or not. Treatment details were not reported.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Chills, Cough, Headache, Myalgia
Clinical narrative: Pressure in chest; Dry cough; Chills; Pounding headache; Fever; Body aches; Tenderness, soreness in arm; This spontaneous case was reported by a consumer and describes the occurrence of CHEST DISCOMFORT (Pressure in chest), COUGH (Dry cough), MYALGIA (Body aches), VACCINATION SITE PAIN (Tenderness, soreness in arm) and CHILLS (Chills) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included DULOXETINE HYDROCHLORIDE (CYMBALTA) for an unknown indication.    On 05-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, the patient experienced VACCINATION SITE PAIN (Tenderness, soreness in arm). On 06-Feb-2021, the patient experienced MYALGIA (Body aches), HEADACHE (Pounding headache) and PYREXIA (Fever). On an unknown date, the patient experienced CHEST DISCOMFORT (Pressure in chest), COUGH (Dry cough) and CHILLS (Chills). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, CHEST DISCOMFORT (Pressure in chest) outcome was unknown and COUGH (Dry cough), MYALGIA (Body aches), VACCINATION SITE PAIN (Tenderness, soreness in arm), CHILLS (Chills), HEADACHE (Pounding headache) and PYREXIA (Fever) had resolved.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Vaccination site pain
Clinical narrative: Pressure in chest; Dry cough; Chills; Pounding headache; Fever; Body aches; Tenderness, soreness in arm; This spontaneous case was reported by a consumer and describes the occurrence of CHEST DISCOMFORT (Pressure in chest), COUGH (Dry cough), MYALGIA (Body aches), VACCINATION SITE PAIN (Tenderness, soreness in arm) and CHILLS (Chills) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included DULOXETINE HYDROCHLORIDE (CYMBALTA) for an unknown indication.    On 05-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, the patient experienced VACCINATION SITE PAIN (Tenderness, soreness in arm). On 06-Feb-2021, the patient experienced MYALGIA (Body aches), HEADACHE (Pounding headache) and PYREXIA (Fever). On an unknown date, the patient experienced CHEST DISCOMFORT (Pressure in chest), COUGH (Dry cough) and CHILLS (Chills). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, CHEST DISCOMFORT (Pressure in chest) outcome was unknown and COUGH (Dry cough), MYALGIA (Body aches), VACCINATION SITE PAIN (Tenderness, soreness in arm), CHILLS (Chills), HEADACHE (Pounding headache) and PYREXIA (Fever) had resolved.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Chills, Pyrexia, Vaccination site pain
Clinical narrative: feels like a mc truck has ran her over; Chills; Fever of 105.0; tenderness in arm; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 12-Feb-2021 and was forwarded to Moderna on 12-Feb-2021.    This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (feels like a mc truck has ran her over), CHILLS (Chills), PYREXIA (Fever of 105.0) and VACCINATION SITE PAIN (tenderness in arm) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M201A) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ASTHENIA (feels like a mc truck has ran her over), CHILLS (Chills), PYREXIA (Fever of 105.0) and VACCINATION SITE PAIN (tenderness in arm). At the time of the report, ASTHENIA (feels like a mc truck has ran her over), CHILLS (Chills), PYREXIA (Fever of 105.0) and VACCINATION SITE PAIN (tenderness in arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Details regarding concomitant and treatment medications were not provided.
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Chest discomfort, Head discomfort, Headache, Paraesthesia
Clinical narrative: head was woozy; her stomach felt weird; tingly arms and feet at night; dull headache; sensation that something was stuck in her chest; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 11-Feb-2021 and was forwarded to Moderna on 11-Feb-2021.    This spontaneous case was reported by a consumer and describes the occurrence of CHEST DISCOMFORT (sensation that something was stuck in her chest), HEAD DISCOMFORT (head was woozy), ABDOMINAL DISCOMFORT (her stomach felt weird), PARAESTHESIA (tingly arms and feet at night) and HEADACHE (dull headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Feb-2021, the patient experienced CHEST DISCOMFORT (sensation that something was stuck in her chest). On 07-Feb-2021, the patient experienced HEADACHE (dull headache). On 08-Feb-2021, the patient experienced HEAD DISCOMFORT (head was woozy), ABDOMINAL DISCOMFORT (her stomach felt weird) and PARAESTHESIA (tingly arms and feet at night). On 06-Feb-2021, CHEST DISCOMFORT (sensation that something was stuck in her chest) had resolved. On 11-Feb-2021, ABDOMINAL DISCOMFORT (her stomach felt weird) had resolved. At the time of the report, HEAD DISCOMFORT (head was woozy), PARAESTHESIA (tingly arms and feet at night) and HEADACHE (dull headache) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Details regarding concomitant and treatment medications were not provided. The patient confirmed that she was feeling improved, however was still experiencing headache. She wanted to know if the symptoms she had were a delayed reaction to the vaccine and she also wanted to confirm if the Moderna vaccine contained aborted fetus cells or not.
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Depression, Fatigue
Clinical narrative: Exhaustion and depression side effects for 7 to 8 days; Exhaustion and depression side effects for 7 to 8 days; This spontaneous case was reported by a consumer and describes the occurrence of DEPRESSION (Exhaustion and depression side effects for 7 to 8 days) and FATIGUE (Exhaustion and depression side effects for 7 to 8 days) in a 78-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Asthma (No medical reported history). Concomitant products included CAPECITABINE and CAPECITABINE (XELODA) for an unknown indication.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DEPRESSION (Exhaustion and depression side effects for 7 to 8 days) and FATIGUE (Exhaustion and depression side effects for 7 to 8 days). At the time of the report, DEPRESSION (Exhaustion and depression side effects for 7 to 8 days) and FATIGUE (Exhaustion and depression side effects for 7 to 8 days) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   The  patient was using an inhaler for asthma (details regarding medication not provided). Patient also reported that treatment medications for exhaustion  and depression were taken (details not provided).  Crosslinked to case, MOD21-022704.   Most recent FOLLOW-UP information incorporated above includes: On 15-Jun-2021: Reporter information updated.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster, Lymphadenopathy, Mass, Vaccination site mass, Vaccination site pain
Clinical narrative: Shingles; bump moved to chest; Bump at the injection site moving to the chest and arm pit; mass under arm pit; Pain at the injection site; This spontaneous case was reported by a health care professional (subsequently medically confirmed) and describes the occurrence of HERPES ZOSTER (Shingles), MASS (bump moved to chest), VACCINATION SITE MASS (Bump at the injection site moving to the chest and arm pit), LYMPHADENOPATHY (mass under arm pit) and VACCINATION SITE PAIN (Pain at the injection site) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, the patient experienced VACCINATION SITE PAIN (Pain at the injection site). On 12-Feb-2021, the patient experienced MASS (bump moved to chest), VACCINATION SITE MASS (Bump at the injection site moving to the chest and arm pit) and LYMPHADENOPATHY (mass under arm pit). On 14-Feb-2021, the patient experienced HERPES ZOSTER (Shingles). The patient was treated with GABAPENTIN on 14-Feb-2021 for Shingles, at a dose of UNK dosage form and unknown (ANTIVIRALS) on 14-Feb-2021 for Shingles, at an unspecified dose and frequency. At the time of the report, HERPES ZOSTER (Shingles), MASS (bump moved to chest), VACCINATION SITE MASS (Bump at the injection site moving to the chest and arm pit), LYMPHADENOPATHY (mass under arm pit) and VACCINATION SITE PAIN (Pain at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site induration, Vaccination site pruritus, Vaccination site rash, Vaccination site swelling, Vaccination site warmth
Clinical narrative: Injection site feels warm; Injection site feels hard; Injection site itching; Rash on the injection site; Injection site swollen; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Injection site feels warm), VACCINATION SITE INDURATION (Injection site feels hard), VACCINATION SITE PRURITUS (Injection site itching), VACCINATION SITE RASH (Rash on the injection site) and VACCINATION SITE SWELLING (Injection site swollen) in a 92-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038K20A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, the patient experienced VACCINATION SITE WARMTH (Injection site feels warm), VACCINATION SITE INDURATION (Injection site feels hard), VACCINATION SITE PRURITUS (Injection site itching), VACCINATION SITE RASH (Rash on the injection site) and VACCINATION SITE SWELLING (Injection site swollen). At the time of the report, VACCINATION SITE WARMTH (Injection site feels warm), VACCINATION SITE INDURATION (Injection site feels hard), VACCINATION SITE PRURITUS (Injection site itching), VACCINATION SITE RASH (Rash on the injection site) and VACCINATION SITE SWELLING (Injection site swollen) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test
Clinical narrative: positive for covid; This spontaneous case was reported by an other health care professional (subsequently medically confirmed) and describes the occurrence of COVID-19 (positive for covid) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes and Hypertension.    On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Jan-2021, the patient experienced COVID-19 (positive for covid). At the time of the report, COVID-19 (positive for covid) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 12-Jan-2021, SARS-CoV-2 test: positive (Positive) Tested positive for Covid.     mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient reported using medications for Diabetes and Hypertension concomitantly. Patient was Asymptomatic for COVID. No treatment medications were reported.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Fatigue, Flushing, Headache, Myalgia
Clinical narrative: feeling a little flushed around the face; headache; tired; Chills; Muscle aches; This spontaneous case was reported by a consumer and describes the occurrence of FLUSHING (feeling a little flushed around the face), FATIGUE (tired), CHILLS (Chills), MYALGIA (Muscle aches) and HEADACHE (headache) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Feb-2021, the patient experienced FATIGUE (tired), CHILLS (Chills) and MYALGIA (Muscle aches). On 11-Feb-2021, the patient experienced FLUSHING (feeling a little flushed around the face) and HEADACHE (headache). At the time of the report, FLUSHING (feeling a little flushed around the face), FATIGUE (tired), CHILLS (Chills), MYALGIA (Muscle aches) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported. Treatment information was not provided.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Peripheral swelling, Vaccination site swelling
Clinical narrative: another swelling 5 inch long and 3 inch width, just below the site; swelling like a bump 2inch diameter at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (another swelling 5 inch long and 3 inch width, just below the site) and VACCINATION SITE SWELLING (swelling like a bump 2inch diameter at the injection site) in an adult female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, the patient experienced PERIPHERAL SWELLING (another swelling 5 inch long and 3 inch width, just below the site) and VACCINATION SITE SWELLING (swelling like a bump 2inch diameter at the injection site). At the time of the report, PERIPHERAL SWELLING (another swelling 5 inch long and 3 inch width, just below the site) and VACCINATION SITE SWELLING (swelling like a bump 2inch diameter at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pruritus, Vaccination site rash
Clinical narrative: circular rash at the injection site; left arm was itching around the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (left arm was itching around the injection site) and VACCINATION SITE RASH (circular rash at the injection site) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (left arm was itching around the injection site). On 12-Feb-2021, the patient experienced VACCINATION SITE RASH (circular rash at the injection site). At the time of the report, VACCINATION SITE PRURITUS (left arm was itching around the injection site) and VACCINATION SITE RASH (circular rash at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: pain in my arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (pain in my arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Feb-2021, the patient experienced PAIN IN EXTREMITY (pain in my arm). At the time of the report, PAIN IN EXTREMITY (pain in my arm) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
Age: 89.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Rash, Tremor
Clinical narrative: Numb face; Whole body is shaking; Rash on the left arm which is spreading to the shoulder; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (Numb face), TREMOR (Whole body is shaking) and RASH (Rash on the left arm which is spreading to the shoulder) in an 89-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Feb-2021, the patient experienced HYPOAESTHESIA (Numb face), TREMOR (Whole body is shaking) and RASH (Rash on the left arm which is spreading to the shoulder). At the time of the report, HYPOAESTHESIA (Numb face), TREMOR (Whole body is shaking) and RASH (Rash on the left arm which is spreading to the shoulder) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant  and treatment medication reported
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Herpes virus infection, Palpitations
Clinical narrative: Herpes; Dizziness; Palpitation; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness), PALPITATIONS (Palpitation) and HERPES VIRUS INFECTION (Herpes) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Jan-2021, the patient experienced DIZZINESS (Dizziness), PALPITATIONS (Palpitation) and HERPES VIRUS INFECTION (Herpes). At the time of the report, DIZZINESS (Dizziness), PALPITATIONS (Palpitation) and HERPES VIRUS INFECTION (Herpes) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant information not provided. Treatment information not provided
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Hypersomnia, Myalgia, Pyrexia
Clinical narrative: Fever low grade 100.4; headache; body aches; slept a lot; This spontaneous case was reported by a consumer and describes the occurrence of HYPERSOMNIA (slept a lot), PYREXIA (Fever low grade 100.4), HEADACHE (headache) and MYALGIA (body aches) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, the patient experienced PYREXIA (Fever low grade 100.4), HEADACHE (headache) and MYALGIA (body aches). In February 2021, the patient experienced HYPERSOMNIA (slept a lot). On 12-Feb-2021, PYREXIA (Fever low grade 100.4) outcome was unknown, HEADACHE (headache) and MYALGIA (body aches) had resolved. In February 2021, HYPERSOMNIA (slept a lot) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant information not provided. Treatment information not provided
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling
Clinical narrative: itching near the injection site; swelling near the injection site; Redness near the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (itching near the injection site), VACCINATION SITE SWELLING (swelling near the injection site) and VACCINATION SITE ERYTHEMA (Redness near the injection site) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included COVID-19 in July 2020.    On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (itching near the injection site), VACCINATION SITE SWELLING (swelling near the injection site) and VACCINATION SITE ERYTHEMA (Redness near the injection site). At the time of the report, VACCINATION SITE PRURITUS (itching near the injection site), VACCINATION SITE SWELLING (swelling near the injection site) and VACCINATION SITE ERYTHEMA (Redness near the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant information included Itching Cream Treatment included ice and an itching relief cream for symptom relief.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Bronchitis, COVID-19
Clinical narrative: Bronchitis; Tested positive for COVID; This spontaneous case was reported by a consumer and describes the occurrence of BRONCHITIS (Bronchitis) and COVID-19 (Tested positive for COVID) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025520A) for COVID-19 vaccination.    Co-suspect product included non-company product DULAGLUTIDE (TRULICITY) for an unknown indication.    Concurrent medical conditions included Diabetes, Chronic kidney disease stage 4 and Asthma. Concomitant products included INSULIN ASPART, INSULIN ASPART PROTAMINE (NOVOLOG MIX) for an unknown indication.   On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient started DULAGLUTIDE (TRULICITY) (unknown route) at an unspecified dose. On 25-Jan-2021, the patient experienced BRONCHITIS (Bronchitis) and COVID-19 (Tested positive for COVID). At the time of the report, BRONCHITIS (Bronchitis) and COVID-19 (Tested positive for COVID) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information not provided
Age: 88.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: sore left arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore left arm) in an 88-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination.     No medical history was provided.     On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (sore left arm). At the time of the report, PAIN IN EXTREMITY (sore left arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use includes Blood pressure medication and Cholesterol medication  No treatment information was provided   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 04-Jun-2021: Received report on 04-JUN-2021 and does not contain any new information.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pruritus, Injection site rash
Clinical narrative: Injection site rash; Injection site itching/circle on left arm at site of injection; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE RASH (Injection site rash) and INJECTION SITE PRURITUS (Injection site itching/circle on left arm at site of injection) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041120A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included Thyroid Medicine for an unknown indication.    On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Jan-2021, the patient experienced INJECTION SITE RASH (Injection site rash) and INJECTION SITE PRURITUS (Injection site itching/circle on left arm at site of injection). At the time of the report, INJECTION SITE RASH (Injection site rash) and INJECTION SITE PRURITUS (Injection site itching/circle on left arm at site of injection) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information not provided
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Burning sensation, Chills, Fatigue, Headache, Peripheral swelling
Clinical narrative: under arm started swelling with burning sensation; under arm started swelling with burning sensation; headache; chills; feels tired; This spontaneous case was reported by a consumer and describes the occurrence of BURNING SENSATION (under arm started swelling with burning sensation), PERIPHERAL SWELLING (under arm started swelling with burning sensation), HEADACHE (headache), CHILLS (chills) and FATIGUE (feels tired) in a 35-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Feb-2021, the patient experienced BURNING SENSATION (under arm started swelling with burning sensation), PERIPHERAL SWELLING (under arm started swelling with burning sensation), HEADACHE (headache), CHILLS (chills) and FATIGUE (feels tired). At the time of the report, BURNING SENSATION (under arm started swelling with burning sensation), PERIPHERAL SWELLING (under arm started swelling with burning sensation), HEADACHE (headache), CHILLS (chills) and FATIGUE (feels tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided. Treatment details were not provided.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Myalgia
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headaches) and MYALGIA (Muscles aches) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination. The patient's past medical history included No adverse event. Concomitant products included ROSUVASTATIN and ORPHENADRINE CITRATE, PARACETAMOL (ANAREX [ORPHENADRINE CITRATE;PARACETAMOL]) for an unknown indication. On 10-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, the patient experienced HEADACHE (Headaches) and MYALGIA (Muscles aches). At the time of the report, HEADACHE (Headaches) and MYALGIA (Muscles aches) outcome was unknown. Not Provided. Treatment information not provided; This case was linked to MOD21-027282.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Dizziness, Fatigue, Gait disturbance, Pain in extremity
Clinical narrative: Dizzy every now and then; Hard to walk; back pain; arm and leg pain; arm and leg pain; Fever between 99.1-100 F; Vomiting; Not been to work; This spontaneous case was reported by an other health care professional and describes the occurrence of DIZZINESS (Dizzy every now and then), GAIT DISTURBANCE (Hard to walk), BACK PAIN (back pain), the first episode of PAIN IN EXTREMITY (arm and leg pain) and the second episode of PAIN IN EXTREMITY (arm and leg pain) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Feb-2021, the patient experienced DIZZINESS (Dizzy every now and then), GAIT DISTURBANCE (Hard to walk), BACK PAIN (back pain), the first episode of PAIN IN EXTREMITY (arm and leg pain), the second episode of PAIN IN EXTREMITY (arm and leg pain), PYREXIA (Fever between 99.1-100 F), VOMITING (Vomiting) and FATIGUE (Not been to work). On 07-Feb-2021, PYREXIA (Fever between 99.1-100 F) outcome was unknown. On 08-Feb-2021, VOMITING (Vomiting) had resolved. At the time of the report, DIZZINESS (Dizzy every now and then), GAIT DISTURBANCE (Hard to walk), BACK PAIN (back pain), the last episode of PAIN IN EXTREMITY (arm and leg pain) and FATIGUE (Not been to work) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant information not provided. Treatment information not provided